Business & Management

Business & Management Experts

Felix Von Coerper

Amylyx Pharmaceuticals Inc
United States of America


Mr. Von Coerper began serving as a director of Amylyx in 2016. Mr. Von Coerper currently is the managing partner of the ALS Investment Fund, a venture capital fund based in the Netherlands exclusively focused on investment in promising ALS technologies. He has over 19 years experience in early stage venture management & finance. He founded a served as CEO of Elana and was CEO of MySample BV. He received his Masters in Economics from the Erasmus University Rotterdam. 

Research Interest

mylyx is developing a proprietary therapeutic for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases that targets the neuroinflammation and nerve cell death that characterize these disorders. The company’s therapeutic, AMX0035, is a proprietary combination of existing compounds that Amylyx has demonstrated have synergistic effects in preventing nerve cell death and neurotoxic inflammation in multiple preclinical models. 

Global Experts from United States of America

Global Experts in Subject

Share This Profile